The latest closing stock price for Fate Therapeutics as of September 19, 2024 is 4.00.
An investor who bought $1,000 worth of Fate Therapeutics stock at the IPO in 2013 would have $-396 today, roughly 0 times their original investment - a -4.48% compound annual growth rate over 11 years.
The all-time high Fate Therapeutics stock closing price was 117.40 on January 14, 2021.
The Fate Therapeutics 52-week high stock price is 8.83, which is 120.8% above the current share price.
The Fate Therapeutics 52-week low stock price is 1.63, which is 59.3% below the current share price.
The average Fate Therapeutics stock price for the last 52 weeks is 4.16.
An investor who bought $1,000 worth of Fate Therapeutics stock at the IPO in 2013 would have $-396 today, roughly 0 times their original investment - a -4.48% compound annual growth rate over 11 years.
The all-time high Fate Therapeutics stock closing price was 117.40 on January 14, 2021.
The Fate Therapeutics 52-week high stock price is 8.83, which is 120.8% above the current share price.
The Fate Therapeutics 52-week low stock price is 1.63, which is 59.3% below the current share price.
The average Fate Therapeutics stock price for the last 52 weeks is 4.16.